RECENT FUNDING ROUNDS
| Company | Country | Profile | Funding round | Value | Date | |
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_company.png?itok=-3VkoHwg){kind=icon}
|
Acologix Inc | Bopharmaceutical company, focuses on the identification, development, commercialization of therapeutic compounds for osteo-renal diseases treatment. | Series C | USD 25,300,000 | ||
|
|
Acologix Inc | Bopharmaceutical company, focuses on the identification, development, commercialization of therapeutic compounds for osteo-renal diseases treatment. | Series B | USD 40,000,000 |
MOST ACTIVE INVESTORS
BEST FUNDED
![[current-page:title] logo](/sites/default/files/styles/thumbnail/public/default_images/_company.png?itok=PsC3hz2r)
Bopharmaceutical company, focuses on the identification, development, commercialization of therapeutic compounds for osteo-renal diseases treatment.
Clinical stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide